Immunoglobulin G is a major plasma glycoprotein containing, on 
The sugar analysis data of IgG obtained from 10 blood donors, nine patients with RA, and six pregnant women are given in Table 1 .
In Table 2 the significance of the differences of the mean monosaccharide and sugar contents is given, calculated with the Mann-Whitney test.
The IgG from patients with RA contained 20% less galactose than IgG from healthy subjects. The mean N-acetylglucosamine content was increased by 20%. The mean fucose and sialic acid contents were not different from normal. In pregnancy the mean galactose content was increased by 13% and the mean sialic acid content by 44%, whereas Nacetylglucosamine and fucose contents were not different from normal.
Discussion
The monosaccharide analysis of IgG from patients with RA shows a significantly lower amount of galactose as compared with IgG from healthy individuals, whereas the N-acetylglucosamine content is significantly higher (Table 1) . Although the analysis of carbohydrate content does not give information about the glycan structure, it is reasonable to assume that the major difference between IgG from patients with RA and from normals is the reduced galactosylation of the diantennary glycans, with a concomitant increase in N-acetylglucosamine content. In an earlier study only the undergalactosylation was indicated.4 It was stated that there are no apparent changes in the levels of the P-N-acetylglucosaminyltransferase enzymes GnT I, GnT II, GnT III, and a(1-6)-fucosyltransferase. As only diantennary structures were detected4 the observed increase of N-acetylglucosamine in this study has to be explained as a change in GnT III activity, responsible for the attachment of the intersecting Nacetylglucosamine. The presence of this sugar residue reduces the galactosylation of the mannose ca(1-3) arm by about 78%.1o Thus if the 20% increase is of N-acetylglucosamine residues of the intersecting type, this would result in a decrease of galactose residues of about 16%, comparable with the 20% that we found. Taken together, our results suggest a 20% increase in intersecting N-acetylglucosamine residues, resulting in undergalactosylation of IgG in patients with RA.
Using a solid phase lectin binding assay, others found that IgG from patients with RA bound significantly more to the immobilised plant lectins peanut agglutinin (PNA) and concanavalin A (con A) than IgG from normals.1' This indicates either an increased content or an increased availability of terminal galactose groups (binding to the PNA lectin) and diantennary sugar chains (binding to the con A lectin). As our results and those obtained by others4 indicate a decreased galactose content and suggest a decreased con A binding owing to the intersecting GlcNAc, a conformational change in the structure of IgG in patients with RA leading to increased lectin binding could explain these results. Indeed, an altered conformation of IgG in RA has recently been suggested. 12 Our findings could support a viral aetiology of the disease. Viruses may alter the glycosylation of cell glycoproteins.13 14 If the IgG producing B cells are infected by a virus, for instance the RA associated Epstein-Barr virus,15 which has a preference for B lymphocytes,16 the result could be a modified glycosylation of IgG produced by the infected cells. This mechanism has been shown to occur in lymphoblastoid cells infected by influenza virus, where decreased glycoprotein sialylation takes place and is only partially compensated for by an increased cellular sialyltransferase.14 Another example is the polyoma virus transformation of baby hamster kidney cells, which induces a twofold increase in the activity of the enzyme GnT V that adds N-acetylglucosamine 11-6 to the al-6 linked mannose.17
If a reduced galactose content of IgG is a prerequisite for the appearance of (some of) the symptoms associated with RA, conditions of increased galactosylation could form a compensation and could be the basis of a therapeutic approach. Such a condition may exist for IgG during pregnancy or oestrogen therapy, two processes where an increased glycosylation of other plasma glycoproteins has been found. 5 Our results show that a significant increase (13%) of the galactose content of IgG occurs during pregnancy. The galactose content of IgG in pregnancy is 42% higher then in the RA group. Thus a partial compensation during pregnancy of the IgG undergalactosylation in female patients with RA can be imagined. IgG from one female patient with RA during pregnancy was analysed (results not shown). It contained high levels of galactose as found in the pregnancy group, and also high levels of N-acetylglucosamine as found in the RA group. Owing to the slight variation in carbohydrate analysis within each group this result has to be confirmed by carbohydrate analysis of IgG obtained from a larger number of pregnant women with RA.
Together with an increase of IgG galactose during pregnancy an increase of sialic acid is also found. This suggests a more complete glycosylation of the diantennary glycans of IgG during pregnancy. The N-acetylglucosamine content of IgG during pregnancy is not different from normal.
Given the fact that the half life of IgG in the circulation is approximately three weeks, the recurrence of symptoms in female patients with RA a few weeks after delivery can also be explained, because the more galactosylated and sialylated IgG produced during pregnarfcy will be gradually replaced by the RA associated undergalactosylated IgG with possible aggregating properties produced thereafter. Alternatively, the increased N-acetylglucosamine content of RA IgG could also have a role, but no decrease has been found to occur during pregnancy. The changes in IgG glycosylation in pregnancy may be due to the altered hormonal state. Oestrogens5 18 and prolactin'9 do influence glycoprotein glycosylation. The association between autoimmune diseases such as RA and steroid hormones has been well described.2t 21 Oral contraceptives2223 and the number of pregnancies24 have an influence as well. It is tempting to suggest the glycosylation of IgG as a key mediator in the occurrence of symptoms in RA.
Studies with asialylated IgG prepared in vitro underline the relation between the IgG glycosylation and rheumatoid factors. 25 26 It would be of interest, in view of our results mentioned above, to extend these experiments with asialo-agalacto IgG prepared in vitro. Other studies have shown that differences in glycosylation of one Fab arm exist between precipitating and non-precipitating antibodies. 27 28 Thus the characteristics of IgG are delicately dependent on the glycosylation of the molecule.
The fact that remission of the symptoms often occurs in women with RA during pregnancy, together with our finding of an increase in IgG galactosylation in healthy pregnant women, supports the view4 that IgG glycosylation could have an important role in the disease. The carbohydrate analysis of IgG of female patients with RA during pregnancy and the investigation of aggregating characteristics of asialo-agalacto IgG prepared in vitro could clarify this point.
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